Predicting heart function using echocardiography and body composition data
Official title: AI-based Prediction of Cardiac Function Using Echocardiography and Body Composition Data (ECHO-FIT Study)
Run by Yonsei University · NCT06811519 · Data updated 2026-11-12
This study is testing if combining heart ultrasound results with body composition data can help predict heart function in people with and without heart failure.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 20 Years and up |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | Yonsei University Academic / other |
| Locations | 1 site (Yongin, Gyeonggi-do) |
| Status | Recruiting |
| Started | February 24, 2025 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2028 |
| Registry record updated | March 4, 2025 |
| Trial ID | NCT06811519 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 20 years or older who are undergoing routine echocardiography.
✕Probably not a fit
Patients with physical or mental conditions that prevent them from undergoing echocardiography or body composition analysis may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to develop and validate a predictive model for cardiac function, specifically left ventricular ejection fraction (LVEF), by combining echocardiographic measurements with body composition data from the QCCUNIQ BC 720 device. It will enroll 2,000 adult participants, half with normal LVEF and half with heart failure, to undergo standard echocardiography and body composition analysis. The study seeks to analyze the relationships between echocardiographic parameters and body composition measures to create a non-invasive prediction model for identifying individuals at higher risk of cardiac dysfunction.
Why it matters
Potential benefit: If successful, this study could enhance early detection and personalized management of heart failure.
How similar studies have gone: Other studies have shown promise in using similar approaches to integrate echocardiographic and body composition data, but this specific model is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 20 years or older. * Undergoing a standard echocardiographic examination. * Providing consent to undergo body composition analysis. * Signing the informed consent form to voluntarily participate in the study. Exclusion Criteria: * Having a physical or mental condition that makes it impossible to conduct an echocardiogram or perform body composition analysis. * Deemed inappropriate for study participation by the researcher (e.g., unable to cooperate).
Where it's running
-
Yongin Severance Hospital
Yongin, Gyeonggi-do, South Korea Recruiting
Study contacts
- Principal investigator: In Hyun Jung, MD., PhD. — Severance Hospital
- Study coordinator: SungA Bae, MD., PhD.
- Email: cardiobsa@yuhs.ac
- Phone: 01023273578
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Registry collecting imaging data for patients with atrial fibrillation
This study is collecting imaging data from patients with atrial fibrillation to see if artificial intelligence can help predict blood clots in the heart before they undergo treatment.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Hybrid ablation for treating persistent atrial fibrillation
This study is testing a new hybrid treatment for people with persistent atrial fibrillation to see if it works better than the standard catheter procedure in helping them stay free from heart rhythm problems.
-
AI-assisted whole-course management for safe medicine use in advanced solid tumors
A real-world study compares a smartphone-based digital management system with usual care to see if it reduces drug-related problems and healthcare needs for adults with advanced solid tumors receiving cancer therapy.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.